Differential expression of <i>HAVCR2</i> gene in pan-cancer: A potential biomarker for survival and immunotherapy.

导出 LinkOut

翻译打印收藏纠错

作者： Hetong,Li ^[1] ; Dinglong,Yang ^[1] ; Min,Hao ^[2] ; Hongqi,Liu ^[1]

作者单位： Second Clinical Medical College, Shanxi Medical University, Taiyuan, China. ^[1] Department of Obstetrics and Gynecology, The Second Hospital of Shanxi Medical University, Taiyuan, China. ^[2] Department of Information Management, The Second Hospital of Shanxi Medical University, Taiyuan, China. ^[3]

关键词 HAVCR2 TIM-3 immune checkpoints immunotherapy pan-cancer

DOI 10.3389/fgene.2022.972664

PMID 36081997

发布时间 2022-09-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in genetics

2022年13卷

972664页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Differential expression of <i>HAVCR2</i> gene in pan-cancer: A potential biomarker for survival and immunotherapy.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Differential expression of <i>HAVCR2</i> gene in pan-cancer: A potential biomarker for survival and immunotherapy.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

检索历史清除